Low grade endometrial endometrioid adenocarcinoma: A review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features

被引:9
作者
Lucas, Elena [1 ]
Carrick, Kelley S. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA
关键词
Endometrioid adenocarcinoma; Endometrial; Variants; Mimics; Low-grade; SURFACE EPITHELIAL CHANGES; CLEAR-CELL CARCINOMAS; MUCINOUS ADENOCARCINOMA; UTERINE CORPUS; MICROGLANDULAR ADENOCARCINOMA; CLINICOPATHOLOGICAL ANALYSIS; PROGESTERONE-RECEPTOR; INTERNATIONAL SOCIETY; ADENOMA MALIGNUM; MUTATIONS;
D O I
10.1053/j.semdp.2022.02.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Endometrioid adenocarcinoma (ECa) may feature a number of morphologic variations that can pose diagnostic challenge. The purpose of this review and update is to examine the spectrum of morphologic variants and mimics of low-grade (FIGO grades 1 and 2) ECa, with a focus on histologic, immunohistochemical, and molecular features that may inform diagnosis and treatment. In addition to ECa of usual type, variants with unique cyto-logic and/or architectural features presented include the following: 1) ECa with mucinous differentiation of conventional (Mullerian) type; 2) ECa with squamous differentiation; 3) ECa with morular metaplasia; 4) ECa with patterns resembling cervical transformation zone tissue and/or microglandular hyperplasia; 5) ECa with cytoplasmic clearing; 6) ECa with papillation, including villoglandular variant of ECa, ECa with small nonvillous papillae, and ECa with a "low-grade serous"-like component or surface changes mimicking ovarian serous borderline tumor; 7) corded and hyalinized variant of ECa; 8) ECa with spindled epithelial cells; 9) ECa with sex cord-like pattern; and 10) ECa with other unusual cytologic and associated features. For each variant, relevant differential diagnoses and diagnostic strategies are discussed. The most clinically significant distinctions come into play in the differential diagnosis between low-grade ECa and one of its high-grade mimics. In this setting, the most fundamental tool in the pathologist's diagnostic arsenal is recognition of the low-grade cytologic features typical of low-grade ECa. Circumspect evaluation of cytologic features, complemented by an awareness of the morphologic spectrum, an appropriate battery of immunohistochemical stains when needed, and mindfulness of the clinical scenario, should guide the pathologist to the correct histotype in even challenging cases.
引用
收藏
页码:159 / 175
页数:17
相关论文
共 122 条
  • [1] Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus
    Abiko, Kaoru
    Baba, Tsukasa
    Ogawa, Madoka
    Mikami, Yoshiki
    Koyama, Takashi
    Mandai, Masaki
    Konishi, Ikuo
    [J]. PATHOLOGY INTERNATIONAL, 2010, 60 (01) : 42 - 47
  • [2] PAX2 Loss by Immunohistochemistry Occurs Early and Often in Endometrial Hyperplasia
    Allison, Kimberly H.
    Upson, Kristen
    Reed, Susan D.
    Jordan, Carolyn D.
    Newton, Katherine M.
    Doherty, Jennifer
    Swisher, Elizabeth M.
    Garcia, Rochelle L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (02) : 159 - 167
  • [3] AMBROS RA, 1994, AM J SURG PATHOL, V18, P569
  • [4] Endometrial Carcinomas with Intestinal-Type Metaplasia/Differentiation: Does Mismatch Repair System Defects Matter? Case Report and Systematic Review of the Literature
    Ardighieri, Laura
    Palicelli, Andrea
    Ferrari, Federico
    Bugatti, Mattia
    Drera, Emma
    Sartori, Enrico
    Odicino, Franco
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 13
  • [5] Endometrial Carcinomas: A Review Emphasizing Overlapping and Distinctive Morphological and Immunohistochemical Features
    Bartosch, Carla
    Lopes, Jose Manuel
    Oliva, Esther
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2011, 18 (06) : 415 - 437
  • [6] BERGER G, 1984, Applied Pathology, V2, P63
  • [7] Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
    Bernardini, Marcus Q.
    Gien, Lilian T.
    Lau, Susie
    Altman, Alon D.
    Gilks, Blake
    Ferguson, Sarah E.
    Koebel, Martin
    Samouelian, Vanessa
    Wesa, Mina
    Cameron, Anna
    Nelson, Gregg
    Han, Guangming
    Clarke, Blaise
    Ho, T. C.
    Panzarella, Tony
    Atenafu, Eshetu G.
    McAlpine, Jessica N.
    [J]. GYNECOLOGIC ONCOLOGY, 2016, 141 (01) : 148 - 154
  • [8] Bosse T, 2020, Female Genital Tumours, P252
  • [9] Endometrial Adenocarcinoma With Signet Ring Cells: Report of Two Cases of an Extremely Rare Phenomenon
    Boyd, Clinton
    Cameron, Iain
    McCluggage, W. Glenn
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2010, 29 (06) : 579 - 582
  • [10] Endometrioid adenocarcinoma with simultaneous endocervical and intestinal-type mucinous differentiation: report of a rare phenomenon and the immunohistochemical profile
    Buell-Gutbrod, Rebecca
    Sung, C. James
    Lawrence, W. Dwayne
    Quddus, M. Ruhul
    [J]. DIAGNOSTIC PATHOLOGY, 2013, 8